Publisher
Springer Science and Business Media LLC
Reference178 articles.
1. Medler, J., Kucka, K. & Wajant, H. Tumor necrosis factor receptor 2 (TNFR2): an emerging target in cancer therapy. Cancers 14, 2603 (2022).
2. Medler, J. & Wajant, H. Tumor necrosis factor receptor-2 (TNFR2): an overview of an emerging drug target. Expert Opin. Ther. Targets 23, 295–307 (2019).
3. Rolski, F. & Błyszczuk, P. Complexity of TNF-α signaling in heart disease. J. Clin. Med. 9, 3267 (2020).
4. Salomon, B. L. Insights into the biology and therapeutic implications of TNF and regulatory T cells. Nat. Rev. Rheumatol. 17, 487–504 (2021).
5. Zahid, M. et al. Tumor necrosis factor alpha blockade and multiple sclerosis: exploring new avenues. Cureus 13, e18847 (2021).
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献